Cole Ryan (CIK 2126966) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-20). Recent activity: Buy AUPH (116,144 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-20 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Operating Officer | Buy | 116,144 | $0 |
Source: SEC Form 4 filings · as of 2026-05-20